Education
About Us
Working with TipRanks
Follow Us
Ligand Pharma (LGND)
NASDAQ:LGND
Ligand Pharma (LGND) Ownership Overview
2.69% Insiders
38.24% Mutual Funds
25.31% Other Institutional Investors
26.85% ETFs
6.91% Public Companies and
Individual Investors
The ownership structure of Ligand Pharma (LGND) stock is a mix of institutional, retail, and individual investors. Approximately 90.40% of the company’s stock is owned by Institutional Investors, 2.69% is owned by Insiders, and 6.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 06, 2025 | xxxxxxxxxxxxx | $575100 | |
| Dec 26, 2024 | xxxxxxxxxxxxx | $244842 | |
| Dec 02, 2024 | John Lamattina Director | xxxxxxxxxxxxx | $297502 |
| Sep 25, 2024 | Andrew Reardon Clo & Secretary | xxxxxxxxxxxxx | $199200 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $310413 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $535535 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $10783361 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $14324883 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,189,554 | Institution | 11.37% | 240,741,462 | |
| 1,886,098 | Institution | 9.80% | 207,376,475 | |
| 1,625,834 | Institution | 8.44% | 178,760,448 | |
| 899,320 | Institution | 4.67% | 98,880,234 | |
| 655,863 | Institution | 3.41% | 72,112,137 | |
| 387,499 | Institution | 2.01% | 42,605,515 | |
| 383,895 | Institution | 1.99% | 42,209,255 | |
| 333,721 | Institution | 1.73% | 36,692,624 | |
| 324,006 | Institution | 1.68% | 35,624,460 | |
| 280,208 | Institution | 1.46% | 30,808,870 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,625,834 | Institution | 8.44% | 178,760,448 | |
| 899,320 | Institution | 4.67% | 98,880,234 | |
| 655,863 | Institution | 3.41% | 72,112,137 | |
| 387,499 | Institution | 2.01% | 42,605,515 | |
| 383,895 | Institution | 1.99% | 42,209,255 | |
| 324,006 | Institution | 1.68% | 35,624,460 | |
| 280,208 | Institution | 1.46% | 30,808,870 | |
| 270,964 | Institution | 1.41% | 29,792,492 | |
| 259,157 | Institution | 1.35% | 28,494,312 | |
| 232,087 | Institution | 1.21% | 25,517,966 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,193,597 | Institution | 6.20% | 126,748,065 | |
| 577,202 | Institution | 3.00% | 70,551,400 | |
| 464,205 | Institution | 2.41% | 51,039,340 | |
| 457,103 | Institution | 2.37% | 48,978,586 | |
| 301,730 | Institution | 1.57% | 36,880,458 | |
| 290,828 | Institution | 1.51% | 35,547,906 | |
| 167,582 | Institution | 0.87% | 17,795,533 | |
| 158,745 | Institution | 0.82% | 17,454,013 | |
| 105,726 | Institution | 0.55% | 11,227,044 | |
| 94,793 | Institution | 0.49% | 10,422,490 |
FAQ
Who Owns Ligand Pharma (LGND)?
According to the latest TipRanks data, approximately 25.31% of the company's stock is held by institutional investors, 2.69% is held by insiders, and 6.91% is held by retail investors.
What percentage of Ligand Pharma (LGND) stock is held by institutional investors?
According to the latest TipRanks data, approximately 25.31% of Ligand Pharma (LGND) stock is held by institutional investors.
What percentage of Ligand Pharma (LGND) stock is held by retail investors?
According to the latest TipRanks data, approximately 6.91% of Ligand Pharma (LGND) stock is held by retail investors.
Who owns the most shares of Ligand Pharma (LGND)?
iShares owns the most shares of Ligand Pharma (LGND).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.